Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar

Thread starter U.S. News
Start date Oct 30, 2025

U.S. News

Guest

Oct 30, 2025

The results come as Eli Lilly works to maintain its edge over Novo Nordisk in the booming market for a class of obesity and diabetes drugs called GLP-1s.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar

Prefix: N/A

Forum: USA News

Start date: Oct 30, 2025

Last reply date: Oct 30, 2025

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Oct 30, 2025

Replies: 0

Views: 18

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search